Piasclédine 300mg box of 60 capsules
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Free delivery for orders over 89€*.
* in metropolitan France and excluding drugs
Ostenil Plus is a transparent solution of natural and highly purified hyaluronic acid, obtained by bacterial fermentation and free of animal proteins. Ostenil Plus also contains mannitol, a free radical scavenger, which helps stabilize the hyaluronic acid chains. Biocompatibility studies have shown that Ostenil Plus is well tolerated.
Pain and reduced mobility in degenerative and traumatic changes of the knee joint and other synovial joints.
Inject Ostenil Plus into the affected joint once a week, for a total of 1 to 3 injections.
Several joints can be treated simultaneously.
Treatment cycles can be repeated if necessary.
In case of joint effusion, it is advisable to reduce the effusion by suction, rest, application of an ice pack and/or intra-articular injection of a corticosteroid. Treatment with Ostenil Plus can then be resumed two to three days later.
The contents and outer surface of the Ostenil Plus pre-filled syringe remain sterile as long as the sterile packaging remains intact. Remove the pre-filled syringe from the sterile package. Before use, the safety closure of the pre-filled syringe must be broken. Break off the crosspiece of the safety closure. The tip can be removed with the cap. Attach a suitable needle (e.g. 18 to 25 G) and ensure that it is securely attached by turning it slightly. Before injection, make sure that any air bubbles are removed from the syringe.
History of hypersensitivity to any of the components.
Particular care should be taken in patients with known hypersensitivity to drugs.
General precautions for intra-articular injections should be taken, including measures to avoid joint infection.
Ostenil Plus should be injected specifically into the joint cavity, if necessary under fluoroscopic guidance. Avoid injection into blood vessels and surrounding tissue.
In the absence of clinical data on the use of hyaluronic acid in children, pregnant or breastfeeding women, or in inflammatory joint diseases such as rheumatoid arthritis or Bekhterev's disease, the administration of Ostenil Plus is not recommended in these patients.
Do not use if the pre-filled syringe or sterile packaging is damaged.
To date, no data are available on the incompatibility of Ostenil Plus with other intra-articular solutions. Simultaneous use of analgesics or oral anti-inflammatory medication during the first few days of treatment may be helpful to the patient.
Local manifestations such as pain, heat, redness and swelling may occur in the joint treated with Ostenil Plus. The application of an ice pack for 5 to 10 minutes to the treated area will reduce the incidence of these effects.
Store at room temperature not exceeding 25°C.
Do not use after the expiry date stated on the box.
Keep out of reach of children.
Specific References
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.
Intra-articular injection of hyaluronic acid forarthropathy causing pain or limited mobility. This medical device is a regulated healthcare product, and carries the CE mark.
- Restore the viscoelastic properties of synovial fluid
- Reduce pain
- Improve joint mobility
Indication : Sinovial® One is indicated in case of pain or limitations of mobility due to degenerative or post-traumatic affections or to alterations of the joint and tendons, in order to restore the physiological and rheological conditions of arthrosic joints.
1 pre-filled syringe of 2.5ml 50MG/2.5 ML of hyaluronic acid
Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.
Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations.
Arthrum is indicated for the symptomatic treatment of gonarthrosis (osteoarthritis of the knee), as prescribed by a rheumatologist. Arthrum 75 solution for injection is a viscoelastic preparation contained in a 3 ml pre-filled syringe.
Intra-articular injection at knee level
On prescription only. Please send us your prescription by clicking here
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Description : GCA2700 Gel combines 16 targeted active ingredients, including Harpagophytum extract, Helichrysum floral water and Gaultheria essential oil with a soothing and relaxing fragrance.
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Indications: Phytostandard of harpagophytum and willow Pileje is a food supplement to improve joint comfort.
The extracts of harpagophytum and willow are obtained through the patented Phytostandard® process known for its respect for the integrity of the plant's compounds.
Description: HYALEXO EXPANSCIENCE is a hyaluronic acid-based medical device indicated for the relief of pain in patients suffering fromosteoarthritis or degenerative joint diseases resulting in an alteration of the functional properties of synovial fluid.
Injection treatment of mild to moderate osteoarthritis of the knee or hip.
DUROLANE® has also been approved for the symptomatic treatment associated with mild to moderate osteoarthritis pain of the ankles, shoulders, elbows, wrists, fingers and toes.
Pain relief improves joint function and helps restore quality of life.
Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.
Symptomatic treatment ofosteoarthritis.
Arthrum H viscoelastic devices are recommended to maintain the endo-articular space, reduce pain and restore joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in osteoarthritic joints.
Indications: This product is indicated in adults (over 15 years of age) for the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and contusions. This drug is indicated in adults for the treatment of painful flare-ups of osteoarthritis of the knee, following initial medical advice.